29 completed, 6 terminated, 3 active not recruiting, 3 recruiting. 46 Phase 1, 16 Phase 2.
Follow Hydrocortisone: new trials by email Literature Review of Hydrocortisone trials Research Report on Hydrocortisone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 1 | Withdrawn | Children's Oncology Group | 2026-09-10 | 2026-05-05 | |
| GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy Hydrocortisone, Pancreatic resection - Pancreatic Cancer, Pancreatic Adenocarcinoma | Phase 1 | Not yet recruiting | University of Illinois at Chicago | 20 | 2026-09-01 | 2026-09-01 |
| Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL) Asciminib Adult formulation, Asciminib Pediatric formulation, Dexamethasone - Acute Lymphoblastic Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | Phase 1 / Phase 2 | Recruiting | Novartis Pharmaceuticals | 50 | 2026-07-05 | 2026-11-12 |
| A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Myelodysplastic Syndrome | Phase 1 | Recruiting | Children's Oncology Group | 36 | 2025-02-04 | 2026-08-25 |
| A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001) Opevesostat, Dexamethasone, Fludrocortisone - Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer | Phase 1 | Completed | Merck Sharp & Dohme LLC | 14 | 2024-01-30 | 2026-03-19 |
| A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) Opevesostat, Dexamethasone, Fludrocortisone acetate - Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer | Phase 1 | Completed | Merck Sharp & Dohme LLC | 7 | 2023-11-14 | 2026-04-27 |
| A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat Anti-CD123 ADC IMGN632, Bone Marrow Aspiration and Biopsy, Cytarabine - Recurrent Acute Myeloid Leukemia, Recurrent B Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Withdrawn | Children's Oncology Group | 2023-08-01 | 2023-09-01 | |
| Venetoclax Basket Trial for High Risk Hematologic Malignancies Venetoclax, Azacitidine, Cytarabine - Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary | Phase 1 | Active not recruiting | Andrew E. Place, MD | 14 | 2023-03-29 | 2026-11-18 |
| Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies Tagraxofusp, Fludarabine, Cytarabine - Hematologic Malignancy, AML | Phase 1 | Recruiting | Therapeutic Advances in Childhood Leukemia Consortium | 54 | 2022-11-11 | 2024-12-06 |
| HAT for the Treatment of Sepsis Associated With NASTI HAT, Placebo - Necrotizing Soft Tissue Infection, Sepsis | Phase 1 / Phase 2 | Terminated | Ascension Health | 10 | 2021-09-10 | 2024-07-24 |
| Glucocorticoid Administration After Traumatic Birth Intravenous (IV) hydrocortisone - Traumatic Birth | Phase 1 | Completed | University of Michigan | 133 | 2021-05-21 | 2022-11-09 |
| Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Azacitidine, Cytarabine, Fludarabine Phosphate - Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia | Phase 1 | Completed | National Cancer Institute (NCI) | 12 | 2019-05-17 | 2025-04-13 |
| Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) Palbociclib, Cytarabine, Methotrexate - Leukemia, Lymphocytic, Lymphoblastic Lymphoma | Phase 1 | Completed | Children's Oncology Group | 12 | 2019-04-11 | 2025-03-21 |
| Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL Pevonedistat, Vincristine, Dexamethasone - Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia | Phase 1 | Completed | Julio Barredo, MD | 6 | 2019-03-25 | 2022-10-20 |
| PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Ixazomib, Vincristine, Dexamethasone - ALL, Childhood, Lymphoblastic Lymphoma, Childhood | Phase 1 / Phase 2 | Active not recruiting | Therapeutic Advances in Childhood Leukemia Consortium | 24 | 2019-02-12 | 2025-06-17 |
| A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects Infacort®, Cortef® - Adrenal Insufficiency | Phase 1 | Completed | Neurocrine UK Limited | 51 | 2018-04-16 | 2026-09-14 |
| A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects Chronocort®, Cortef® - Adrenal Insufficiency | Phase 1 | Completed | Neurocrine UK Limited | 25 | 2018-02-19 | 2026-09-14 |
| Hormonal Mechanisms of Sleep Restriction - Axis Study Ketoconazole Pill, Ganirelix, Dexamethasone - Sleep Restriction | Phase 1 | Active not recruiting | Peter y. Liu | 80 | 2017-05-08 | 2025-09-11 |
| Physiologic Effects of Steroids in Cardiac Arrest Methylprednisolone; hydrocortisone, Saline Placebo - Inhospital Cardiac Arrest | Phase 1 / Phase 2 | Completed | University of Athens | 100 | 2016-11-04 | 2021-11-23 |
| Investigating the Central and Peripheral Mechanisms by Which Glucocorticoids Affect Hunger hydrocortisone, saline - Obesity | Phase 1 | Completed | Yale University | 28 | 2016-05-01 | 2022-05-25 |
Showing 20 of 46. Sign in to see all of them.
Precursor Cell Lymphoblastic Leukemia-Lymphoma (12) · Leukemia, Myeloid, Acute (5) · Recurrence (5) · Adrenal Insufficiency (4) · Leukemia, Biphenotypic, Acute (4) · Prostatic Neoplasms (4) · Adrenal Hyperplasia, Congenital (3) · Leukemia (3) · Burkitt Lymphoma (2) · Lymphoma, B-Cell (2) · Lymphoma, T-Cell (2) · Myelodysplastic Syndromes (2) · Pain (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Addison Disease (1)
Neurocrine UK Limited (7) · Children's Oncology Group (5) · Therapeutic Advances in Childhood Leukemia Consortium (4) · Merck Sharp & Dohme LLC (2) · National Cancer Institute (NCI) (2) · X-pert Med GmbH (2) · Amgen (1) · Andrew E. Place, MD (1) · Ascension Health (1) · Beth Israel Deaconess Medical Center (1) · Cairo University (1) · Cristcot LLC (1) · Dana-Farber Cancer Institute (1) · Fred Hutchinson Cancer Center (1) · Haukeland University Hospital (1)
United States (28) · Australia (7) · United Kingdom (4) · Canada (3) · France (3) · Germany (2) · Greece (2) · Israel (2) · Netherlands (2) · Norway (2) · South Korea (2) · Taiwan (2) · Argentina (1) · Austria (1) · Brazil (1)
Elizabeth Raetz, MD (3) · A Koch (2) · Abbot R. Laptook, MD (1) · Abhik Das, PhD (1) · Adam Lamble, MD (1) · Alexandra M Stevens (1) · Andrew E Place, MD, PhD (1) · Aslam Ejaz, MD (1) · Barbara J. Stoll, MD (1) · Barbara Pro, MD (1) · Beau J. Batton, MD (1) · Ben K Watkins (1) · Brenda P. Poindexter, MD MS (1)
PMID 19638218, PMID 22336574, PMID 23650301, PMID 24276047, PMID 26567120, PMID 27038920, PMID 35652112, PMID 36215217, PMID 37172949, PMID 37553297, PMID 38237077, PMID 41586417, PMID 42234929, PMID 42376206
U10CA098543 (2), UM1CA228823 (2), 2014 (1), 2025 (1), F31DA040369 (1), P30CA016056 (1), P30CA060553 (1), R01DK020495 (1), U10CA180886 (1), U10HD021364 (1), U10HD021373 (1), U10HD021385 (1), U10HD027851 (1), U10HD027853 (1), U10HD027856 (1)